Asthma Preventive Market Report

Global Asthma Preventive Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Jun 09, 2022
  • PAGES：152
  • REPORT CODE：GMM863440
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Asthma Preventive market report explains the definition, types, applications, major countries, and major players of the Asthma Preventive market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • GSK

    • Chiesi

    • Merck

    • Boehringer Ingelheim

    • Novartis

    • Astrazeneca

    • Sumitomo Dainippon Pharma

    • Pfizer

    • Amgen

    • Roche

    • Abbot

    • Biotest AG

    By Type:

    • Sodium Cromolyn

    • Prednisolone

    By End-User:

    • Children

    • Adult

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Asthma Preventive Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Asthma Preventive Outlook to 2028- Original Forecasts

    • 2.2 Asthma Preventive Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Asthma Preventive Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Asthma Preventive Market- Recent Developments

    • 6.1 Asthma Preventive Market News and Developments

    • 6.2 Asthma Preventive Market Deals Landscape

    7 Asthma Preventive Raw Materials and Cost Structure Analysis

    • 7.1 Asthma Preventive Key Raw Materials

    • 7.2 Asthma Preventive Price Trend of Key Raw Materials

    • 7.3 Asthma Preventive Key Suppliers of Raw Materials

    • 7.4 Asthma Preventive Market Concentration Rate of Raw Materials

    • 7.5 Asthma Preventive Cost Structure Analysis

      • 7.5.1 Asthma Preventive Raw Materials Analysis

      • 7.5.2 Asthma Preventive Labor Cost Analysis

      • 7.5.3 Asthma Preventive Manufacturing Expenses Analysis

    8 Global Asthma Preventive Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Asthma Preventive Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Asthma Preventive Export by Region (Top 10 Countries) (2017-2028)

    9 Global Asthma Preventive Market Outlook by Types and Applications to 2022

    • 9.1 Global Asthma Preventive Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Sodium Cromolyn Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Prednisolone Consumption and Growth Rate (2017-2022)

    • 9.2 Global Asthma Preventive Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Children Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Adult Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Asthma Preventive Market Analysis and Outlook till 2022

    • 10.1 Global Asthma Preventive Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Asthma Preventive Consumption (2017-2022)

      • 10.2.2 Canada Asthma Preventive Consumption (2017-2022)

      • 10.2.3 Mexico Asthma Preventive Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Asthma Preventive Consumption (2017-2022)

      • 10.3.2 UK Asthma Preventive Consumption (2017-2022)

      • 10.3.3 Spain Asthma Preventive Consumption (2017-2022)

      • 10.3.4 Belgium Asthma Preventive Consumption (2017-2022)

      • 10.3.5 France Asthma Preventive Consumption (2017-2022)

      • 10.3.6 Italy Asthma Preventive Consumption (2017-2022)

      • 10.3.7 Denmark Asthma Preventive Consumption (2017-2022)

      • 10.3.8 Finland Asthma Preventive Consumption (2017-2022)

      • 10.3.9 Norway Asthma Preventive Consumption (2017-2022)

      • 10.3.10 Sweden Asthma Preventive Consumption (2017-2022)

      • 10.3.11 Poland Asthma Preventive Consumption (2017-2022)

      • 10.3.12 Russia Asthma Preventive Consumption (2017-2022)

      • 10.3.13 Turkey Asthma Preventive Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Asthma Preventive Consumption (2017-2022)

      • 10.4.2 Japan Asthma Preventive Consumption (2017-2022)

      • 10.4.3 India Asthma Preventive Consumption (2017-2022)

      • 10.4.4 South Korea Asthma Preventive Consumption (2017-2022)

      • 10.4.5 Pakistan Asthma Preventive Consumption (2017-2022)

      • 10.4.6 Bangladesh Asthma Preventive Consumption (2017-2022)

      • 10.4.7 Indonesia Asthma Preventive Consumption (2017-2022)

      • 10.4.8 Thailand Asthma Preventive Consumption (2017-2022)

      • 10.4.9 Singapore Asthma Preventive Consumption (2017-2022)

      • 10.4.10 Malaysia Asthma Preventive Consumption (2017-2022)

      • 10.4.11 Philippines Asthma Preventive Consumption (2017-2022)

      • 10.4.12 Vietnam Asthma Preventive Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Asthma Preventive Consumption (2017-2022)

      • 10.5.2 Colombia Asthma Preventive Consumption (2017-2022)

      • 10.5.3 Chile Asthma Preventive Consumption (2017-2022)

      • 10.5.4 Argentina Asthma Preventive Consumption (2017-2022)

      • 10.5.5 Venezuela Asthma Preventive Consumption (2017-2022)

      • 10.5.6 Peru Asthma Preventive Consumption (2017-2022)

      • 10.5.7 Puerto Rico Asthma Preventive Consumption (2017-2022)

      • 10.5.8 Ecuador Asthma Preventive Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Asthma Preventive Consumption (2017-2022)

      • 10.6.2 Kuwait Asthma Preventive Consumption (2017-2022)

      • 10.6.3 Oman Asthma Preventive Consumption (2017-2022)

      • 10.6.4 Qatar Asthma Preventive Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Asthma Preventive Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Asthma Preventive Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Asthma Preventive Consumption (2017-2022)

      • 10.7.2 South Africa Asthma Preventive Consumption (2017-2022)

      • 10.7.3 Egypt Asthma Preventive Consumption (2017-2022)

      • 10.7.4 Algeria Asthma Preventive Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Asthma Preventive Consumption (2017-2022)

      • 10.8.2 New Zealand Asthma Preventive Consumption (2017-2022)

    11 Global Asthma Preventive Competitive Analysis

    • 11.1 GSK

      • 11.1.1 GSK Company Details

      • 11.1.2 GSK Asthma Preventive Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 GSK Asthma Preventive Main Business and Markets Served

      • 11.1.4 GSK Asthma Preventive Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Chiesi

      • 11.2.1 Chiesi Company Details

      • 11.2.2 Chiesi Asthma Preventive Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Chiesi Asthma Preventive Main Business and Markets Served

      • 11.2.4 Chiesi Asthma Preventive Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Merck

      • 11.3.1 Merck Company Details

      • 11.3.2 Merck Asthma Preventive Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Merck Asthma Preventive Main Business and Markets Served

      • 11.3.4 Merck Asthma Preventive Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Boehringer Ingelheim

      • 11.4.1 Boehringer Ingelheim Company Details

      • 11.4.2 Boehringer Ingelheim Asthma Preventive Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Boehringer Ingelheim Asthma Preventive Main Business and Markets Served

      • 11.4.4 Boehringer Ingelheim Asthma Preventive Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Novartis

      • 11.5.1 Novartis Company Details

      • 11.5.2 Novartis Asthma Preventive Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Novartis Asthma Preventive Main Business and Markets Served

      • 11.5.4 Novartis Asthma Preventive Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Astrazeneca

      • 11.6.1 Astrazeneca Company Details

      • 11.6.2 Astrazeneca Asthma Preventive Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Astrazeneca Asthma Preventive Main Business and Markets Served

      • 11.6.4 Astrazeneca Asthma Preventive Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Sumitomo Dainippon Pharma

      • 11.7.1 Sumitomo Dainippon Pharma Company Details

      • 11.7.2 Sumitomo Dainippon Pharma Asthma Preventive Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Sumitomo Dainippon Pharma Asthma Preventive Main Business and Markets Served

      • 11.7.4 Sumitomo Dainippon Pharma Asthma Preventive Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Pfizer

      • 11.8.1 Pfizer Company Details

      • 11.8.2 Pfizer Asthma Preventive Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Pfizer Asthma Preventive Main Business and Markets Served

      • 11.8.4 Pfizer Asthma Preventive Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 Amgen

      • 11.9.1 Amgen Company Details

      • 11.9.2 Amgen Asthma Preventive Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 Amgen Asthma Preventive Main Business and Markets Served

      • 11.9.4 Amgen Asthma Preventive Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 Roche

      • 11.10.1 Roche Company Details

      • 11.10.2 Roche Asthma Preventive Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 Roche Asthma Preventive Main Business and Markets Served

      • 11.10.4 Roche Asthma Preventive Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    • 11.11 Abbot

      • 11.11.1 Abbot Company Details

      • 11.11.2 Abbot Asthma Preventive Sales, Price, Value and Gross Profit (2017-2022)

      • 11.11.3 Abbot Asthma Preventive Main Business and Markets Served

      • 11.11.4 Abbot Asthma Preventive Product Portfolio

      • 11.11.5 Recent Research and Development Strategies

    • 11.12 Biotest AG

      • 11.12.1 Biotest AG Company Details

      • 11.12.2 Biotest AG Asthma Preventive Sales, Price, Value and Gross Profit (2017-2022)

      • 11.12.3 Biotest AG Asthma Preventive Main Business and Markets Served

      • 11.12.4 Biotest AG Asthma Preventive Product Portfolio

      • 11.12.5 Recent Research and Development Strategies

    12 Global Asthma Preventive Market Outlook by Types and Applications to 2028

    • 12.1 Global Asthma Preventive Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Sodium Cromolyn Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Prednisolone Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Asthma Preventive Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Children Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Adult Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Asthma Preventive Market Analysis and Outlook to 2028

    • 13.1 Global Asthma Preventive Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Asthma Preventive Consumption Forecast (2022-2028)

      • 13.2.2 Canada Asthma Preventive Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Asthma Preventive Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Asthma Preventive Consumption Forecast (2022-2028)

      • 13.3.2 UK Asthma Preventive Consumption Forecast (2022-2028)

      • 13.3.3 Spain Asthma Preventive Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Asthma Preventive Consumption Forecast (2022-2028)

      • 13.3.5 France Asthma Preventive Consumption Forecast (2022-2028)

      • 13.3.6 Italy Asthma Preventive Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Asthma Preventive Consumption Forecast (2022-2028)

      • 13.3.8 Finland Asthma Preventive Consumption Forecast (2022-2028)

      • 13.3.9 Norway Asthma Preventive Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Asthma Preventive Consumption Forecast (2022-2028)

      • 13.3.11 Poland Asthma Preventive Consumption Forecast (2022-2028)

      • 13.3.12 Russia Asthma Preventive Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Asthma Preventive Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Asthma Preventive Consumption Forecast (2022-2028)

      • 13.4.2 Japan Asthma Preventive Consumption Forecast (2022-2028)

      • 13.4.3 India Asthma Preventive Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Asthma Preventive Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Asthma Preventive Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Asthma Preventive Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Asthma Preventive Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Asthma Preventive Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Asthma Preventive Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Asthma Preventive Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Asthma Preventive Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Asthma Preventive Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Asthma Preventive Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Asthma Preventive Consumption Forecast (2022-2028)

      • 13.5.3 Chile Asthma Preventive Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Asthma Preventive Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Asthma Preventive Consumption Forecast (2022-2028)

      • 13.5.6 Peru Asthma Preventive Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Asthma Preventive Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Asthma Preventive Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Asthma Preventive Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Asthma Preventive Consumption Forecast (2022-2028)

      • 13.6.3 Oman Asthma Preventive Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Asthma Preventive Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Asthma Preventive Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Asthma Preventive Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Asthma Preventive Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Asthma Preventive Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Asthma Preventive Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Asthma Preventive Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Asthma Preventive Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Asthma Preventive Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Asthma Preventive

    • Figure of Asthma Preventive Picture

    • Table Global Asthma Preventive Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Asthma Preventive Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Sodium Cromolyn Consumption and Growth Rate (2017-2022)

    • Figure Global Prednisolone Consumption and Growth Rate (2017-2022)

    • Figure Global Children Consumption and Growth Rate (2017-2022)

    • Figure Global Adult Consumption and Growth Rate (2017-2022)

    • Figure Global Asthma Preventive Consumption by Country (2017-2022)

    • Table North America Asthma Preventive Consumption by Country (2017-2022)

    • Figure United States Asthma Preventive Consumption and Growth Rate (2017-2022)

    • Figure Canada Asthma Preventive Consumption and Growth Rate (2017-2022)

    • Figure Mexico Asthma Preventive Consumption and Growth Rate (2017-2022)

    • Table Europe Asthma Preventive Consumption by Country (2017-2022)

    • Figure Germany Asthma Preventive Consumption and Growth Rate (2017-2022)

    • Figure UK Asthma Preventive Consumption and Growth Rate (2017-2022)

    • Figure Spain Asthma Preventive Consumption and Growth Rate (2017-2022)

    • Figure Belgium Asthma Preventive Consumption and Growth Rate (2017-2022)

    • Figure France Asthma Preventive Consumption and Growth Rate (2017-2022)

    • Figure Italy Asthma Preventive Consumption and Growth Rate (2017-2022)

    • Figure Denmark Asthma Preventive Consumption and Growth Rate (2017-2022)

    • Figure Finland Asthma Preventive Consumption and Growth Rate (2017-2022)

    • Figure Norway Asthma Preventive Consumption and Growth Rate (2017-2022)

    • Figure Sweden Asthma Preventive Consumption and Growth Rate (2017-2022)

    • Figure Poland Asthma Preventive Consumption and Growth Rate (2017-2022)

    • Figure Russia Asthma Preventive Consumption and Growth Rate (2017-2022)

    • Figure Turkey Asthma Preventive Consumption and Growth Rate (2017-2022)

    • Table APAC Asthma Preventive Consumption by Country (2017-2022)

    • Figure China Asthma Preventive Consumption and Growth Rate (2017-2022)

    • Figure Japan Asthma Preventive Consumption and Growth Rate (2017-2022)

    • Figure India Asthma Preventive Consumption and Growth Rate (2017-2022)

    • Figure South Korea Asthma Preventive Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Asthma Preventive Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Asthma Preventive Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Asthma Preventive Consumption and Growth Rate (2017-2022)

    • Figure Thailand Asthma Preventive Consumption and Growth Rate (2017-2022)

    • Figure Singapore Asthma Preventive Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Asthma Preventive Consumption and Growth Rate (2017-2022)

    • Figure Philippines Asthma Preventive Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Asthma Preventive Consumption and Growth Rate (2017-2022)

    • Table South America Asthma Preventive Consumption by Country (2017-2022)

    • Figure Brazil Asthma Preventive Consumption and Growth Rate (2017-2022)

    • Figure Colombia Asthma Preventive Consumption and Growth Rate (2017-2022)

    • Figure Chile Asthma Preventive Consumption and Growth Rate (2017-2022)

    • Figure Argentina Asthma Preventive Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Asthma Preventive Consumption and Growth Rate (2017-2022)

    • Figure Peru Asthma Preventive Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Asthma Preventive Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Asthma Preventive Consumption and Growth Rate (2017-2022)

    • Table GCC Asthma Preventive Consumption by Country (2017-2022)

    • Figure Bahrain Asthma Preventive Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Asthma Preventive Consumption and Growth Rate (2017-2022)

    • Figure Oman Asthma Preventive Consumption and Growth Rate (2017-2022)

    • Figure Qatar Asthma Preventive Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Asthma Preventive Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Asthma Preventive Consumption and Growth Rate (2017-2022)

    • Table Africa Asthma Preventive Consumption by Country (2017-2022)

    • Figure Nigeria Asthma Preventive Consumption and Growth Rate (2017-2022)

    • Figure South Africa Asthma Preventive Consumption and Growth Rate (2017-2022)

    • Figure Egypt Asthma Preventive Consumption and Growth Rate (2017-2022)

    • Figure Algeria Asthma Preventive Consumption and Growth Rate (2017-2022)

    • Table Oceania Asthma Preventive Consumption by Country (2017-2022)

    • Figure Australia Asthma Preventive Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Asthma Preventive Consumption and Growth Rate (2017-2022)

    • Table GSK Company Details

    • Table GSK Asthma Preventive Sales, Price, Value and Gross Profit (2017-2022)

    • Table GSK Asthma Preventive Main Business and Markets Served

    • Table GSK Asthma Preventive Product Portfolio

    • Table Chiesi Company Details

    • Table Chiesi Asthma Preventive Sales, Price, Value and Gross Profit (2017-2022)

    • Table Chiesi Asthma Preventive Main Business and Markets Served

    • Table Chiesi Asthma Preventive Product Portfolio

    • Table Merck Company Details

    • Table Merck Asthma Preventive Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Asthma Preventive Main Business and Markets Served

    • Table Merck Asthma Preventive Product Portfolio

    • Table Boehringer Ingelheim Company Details

    • Table Boehringer Ingelheim Asthma Preventive Sales, Price, Value and Gross Profit (2017-2022)

    • Table Boehringer Ingelheim Asthma Preventive Main Business and Markets Served

    • Table Boehringer Ingelheim Asthma Preventive Product Portfolio

    • Table Novartis Company Details

    • Table Novartis Asthma Preventive Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Asthma Preventive Main Business and Markets Served

    • Table Novartis Asthma Preventive Product Portfolio

    • Table Astrazeneca Company Details

    • Table Astrazeneca Asthma Preventive Sales, Price, Value and Gross Profit (2017-2022)

    • Table Astrazeneca Asthma Preventive Main Business and Markets Served

    • Table Astrazeneca Asthma Preventive Product Portfolio

    • Table Sumitomo Dainippon Pharma Company Details

    • Table Sumitomo Dainippon Pharma Asthma Preventive Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sumitomo Dainippon Pharma Asthma Preventive Main Business and Markets Served

    • Table Sumitomo Dainippon Pharma Asthma Preventive Product Portfolio

    • Table Pfizer Company Details

    • Table Pfizer Asthma Preventive Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Asthma Preventive Main Business and Markets Served

    • Table Pfizer Asthma Preventive Product Portfolio

    • Table Amgen Company Details

    • Table Amgen Asthma Preventive Sales, Price, Value and Gross Profit (2017-2022)

    • Table Amgen Asthma Preventive Main Business and Markets Served

    • Table Amgen Asthma Preventive Product Portfolio

    • Table Roche Company Details

    • Table Roche Asthma Preventive Sales, Price, Value and Gross Profit (2017-2022)

    • Table Roche Asthma Preventive Main Business and Markets Served

    • Table Roche Asthma Preventive Product Portfolio

    • Table Abbot Company Details

    • Table Abbot Asthma Preventive Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abbot Asthma Preventive Main Business and Markets Served

    • Table Abbot Asthma Preventive Product Portfolio

    • Table Biotest AG Company Details

    • Table Biotest AG Asthma Preventive Sales, Price, Value and Gross Profit (2017-2022)

    • Table Biotest AG Asthma Preventive Main Business and Markets Served

    • Table Biotest AG Asthma Preventive Product Portfolio

    • Figure Global Sodium Cromolyn Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Prednisolone Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Children Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Adult Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Asthma Preventive Consumption Forecast by Country (2022-2028)

    • Table North America Asthma Preventive Consumption Forecast by Country (2022-2028)

    • Figure United States Asthma Preventive Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Asthma Preventive Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Asthma Preventive Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Asthma Preventive Consumption Forecast by Country (2022-2028)

    • Figure Germany Asthma Preventive Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Asthma Preventive Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Asthma Preventive Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Asthma Preventive Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Asthma Preventive Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Asthma Preventive Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Asthma Preventive Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Asthma Preventive Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Asthma Preventive Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Asthma Preventive Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Asthma Preventive Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Asthma Preventive Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Asthma Preventive Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Asthma Preventive Consumption Forecast by Country (2022-2028)

    • Figure China Asthma Preventive Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Asthma Preventive Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Asthma Preventive Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Asthma Preventive Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Asthma Preventive Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Asthma Preventive Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Asthma Preventive Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Asthma Preventive Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Asthma Preventive Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Asthma Preventive Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Asthma Preventive Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Asthma Preventive Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Asthma Preventive Consumption Forecast by Country (2022-2028)

    • Figure Brazil Asthma Preventive Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Asthma Preventive Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Asthma Preventive Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Asthma Preventive Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Asthma Preventive Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Asthma Preventive Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Asthma Preventive Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Asthma Preventive Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Asthma Preventive Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Asthma Preventive Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Asthma Preventive Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Asthma Preventive Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Asthma Preventive Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Asthma Preventive Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Asthma Preventive Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Asthma Preventive Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Asthma Preventive Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Asthma Preventive Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Asthma Preventive Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Asthma Preventive Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Asthma Preventive Consumption Forecast by Country (2022-2028)

    • Figure Australia Asthma Preventive Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Asthma Preventive Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US